2 Patents
- US124149662025Method of Treating Diabetes with FGF21 and GLP1 Double Gene-modified Cell
BEIJING JIYUAN BIOLOGICAL TECHNOLOGY CO., Ltd.
0 cites - US117521732023FGF21 and GLP1 Double Gene-modified Mesenchymal Stem Cell and Use in Treating a Metabolic Disease
Beijing Jiyuan Biological Technology Co., Ltd.
0 cites